PETERS KEVIN G. 4
4 · Aerpio Pharmaceuticals, Inc. · Filed Mar 18, 2020
Insider Transaction Report
Form 4
PETERS KEVIN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-16+129,000→ 129,000 totalExercise: $0.52Exp: 2030-03-16→ Common Stock (129,000 underlying)
Footnotes (1)
- [F1]Options exercisable as to 1/4th on March 16, 2021 and an additional 1/48th monthly thereafter until March 16, 2024.